The Neuren Pharmaceuticals Ltd (ASX: NEU) share price may be on watch today after the company delivered an 8% increase in revenue to $42.7 million for the half-year ended 30 June 2026, and announced its first ever dividend.

What did Neuren Pharmaceuticals report?

• Revenue rose 8% to $42.7 million (H1 2025: $39.7 million)
• Net profit after tax dropped 68% to $4.9 million (H1 2025: $15.0 million)
• Basic earnings per share was 3.83 cents (H1 2025: 11.88 cents)
• Fully franked interim dividend of 15 cents per share declared
• Royalty income from DAYBUE (trofinetide) up 29% in US dollars to US$23.3 million
• Research and development costs increased to $27.4 million, up $12.5 million

What else do investors need to know?

Neuren’s royalty income is primarily from DAYBUE sales by Acadia Pharmaceuticals, which posted US$226 million net sales in H1 2026, up 25% on last year. Growth was buoyed by the launch of DAYBUE STIX, a new powder formulation, in the US.

The company’s research spend climbed as it advanced its Phase 3 study of NNZ-2591 in Phelan-McDermid syndrome. Neuren also implemented an on-market share buy-back, repurchasing $3.9 million in shares.

Importantly for shareholders, Neuren’s new dividend policy has resulted in a fully franked interim dividend, to be paid in October. This marks the company’s first ever payout and reflects its confidence in ongoing royalty streams.

What did Neuren Pharmaceuticals management say?

Neuren’s CEO, Jonathan Pilcher, commented:

Neuren’s substantial income from trofinetide means that we are in the enviable position of being able to fund all development programs for NNZ-2591 aiming for significant capital appreciation, as well as optimise total shareholder return through ongoing fully franked dividends.

What’s next for Neuren Pharmaceuticals?

Looking ahead, Neuren expects continued growth in global DAYBUE sales, with Acadia guiding for 2026 net sales of US$480–510 million. The first commercial launch in Europe is targeted for Q4 2026, following a positive opinion from the European Medicines Agency.

Neuren will also focus on progressing its NNZ-2591 clinical programs, with key FDA meetings scheduled and trial sites ramping up for rare neurodevelopmental disorders. Management aims to leverage these investments into further royalty income and milestone payments.

Neuren Pharmaceuticals share price snapshot

The Neuren Pharmaceuticals share price has outperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a gain of over 25%.

View Original Announcement

The post Neuren Pharmaceuticals reports lower profit but launches first dividend appeared first on The Motley Fool Australia.

More reading

• Neuren share price in focus after DAYBU wins EU approval for Rett syndrome
• Here are the top 10 ASX 200 shares today
• 3 ASX 200 stocks storming higher this week on big news
• 5 ASX 200 broker buy ratings
• Are Neuren Pharmaceuticals shares a buy, hold or sell after rocketing 16%?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The COG Financial Services Ltd (ASX: COG) share price is in focus after reporting a 28% lift in EBITDA attributable to shareholders to $51.5 million for FY26, with earnings per share up 27% and a higher final dividend declared.

What did COG Financial Services report?

• EBITDA to shareholders of $51.5 million, up 28% on FY25
• Earnings per share (EPSA) of 15.63 cents, up 27% year on year
• Fully franked final dividend of 3.5 cents per share, up 17%
• Net Assets Financed lifted 8% to $9.0 billion
• Salary packaging customer numbers surged 31% to 68,510
• Novated lease customers up 98% to 22,281

What else do investors need to know?

COG made strategic moves in FY26, acquiring 100% of Easifleet Pty Ltd and lifting its stake in Fleet Network Pty Ltd through subsidiaries. These investments have supported strong customer growth, particularly across the salary packaging and novated leasing lines, with demand bolstered by government electric vehicle incentives.

The Group’s Broking & Aggregation business remained stable, and management noted continued focus on investing in digital platforms to enhance customer experience. COG also maintained its dividend reinvestment plan suspension for the final dividend.

What did COG Financial Services management say?

Chief Executive Officer Andrew Bennett said:

COG’s underlying EBITDA to shareholders grew 28% on the prior year, driven by strong organic growth and disciplined acquisitions. Salary Packaging led the way with 51% revenue growth, thanks to volume gains and a recent acquisition, while the rest of the Group performed solidly despite continued investment in people and systems. These results show the strength of our diversified business and our disciplined approach to growth.

What’s next for COG Financial Services?

Looking ahead, COG targets EBITDA growth of 10% or better in FY27, banking on continued strong results in salary packaging as electric vehicle adoption rises. Management is also backing technology and AI investments to further streamline operations and grow the business.

COG aims to expand its Broking & Aggregation services, reduce client churn, and pursue bolt-on acquisitions if the right opportunities arise. The company also expects further geographic expansion from its Equity-One unit.

COG Financial Services share price snapshot

Over the past 12 months, COG Financial Services shares have declined 18%, trailing the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post COG Financial Services lifts profit 28% and grows dividend for FY26 appeared first on The Motley Fool Australia.

More reading

• GR Engineering Services completes $100 million placement and share purchase plan
• This small-cap ASX technology stock could more than double in value: Broker
• FireFly Metals share price climbs after $190m raise for Green Bay project
• How many Woolworths shares do I need to earn $10,000 per year in passive income?
• Ainsworth Game Technology posts lower H1 FY26 profit and revenue

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

There are many ASX dividend shares on the market that pay investors a consistent, reliable passive income.

The majority of them distribute cash to their shareholders every 6 or 12 months. But did you know there are a handful of shares that pay out much more frequently?

Here are three of my favourite ASX shares that pay dividends every month.

BetaShares Dividend Harvester Active ETF (ASX: HVST) 

HVST is an ASX-listed exchange-traded fund (ETF) that provides investors with exposure to a portfolio of up to 60 dividend-paying shares. It doesn’t track an index; instead, it targets exposure to high-dividend stocks drawn from the 100 largest ASX-listed companies.

Its portfolio is mostly weighted into the financial sector, which accounts for 26.9% of its allocation at the time of writing. The materials sector is second, accounting for 10.1% of its allocation.

And the fund is structured so that it can own a share until it trades ex-dividend. At this point, the fund sells the shares and reinvests the proceeds into its next passive income-generating shares.

HVST pays its shareholders a franked dividend income every single month.  As of the 31st of July, its 12-month gross distribution (dividend) yield is 7.1%, and the net yield is 5.6%. The franking level is 63.3%. The fund’s annual management fee and costs are 0.72%.

The fund paid out $0.06 per share to investors earlier this month. In fact, the fund has paid around $0.06 per share each month since January 2024.

At the time of writing, HVST shares are up around 1% year to date and trading at $13.65 per share.

Metrics Income Opportunities Trust (ASX: MOT)

The MOT is a listed investment trust  (LIT) with a portfolio of private credit and related opportunities. Its portfolio can give investors direct exposure to private credit investments, which have become an increasingly popular asset class.

The Trust said its investment objective is to provide monthly cash income, preserve investor capital, and manage investment risks. It also seeks to provide upside potential through investments in private credit and other assets. These “other assets” include warrants, options, preference shares, and equity.

The Trust targets a cash yield of 7% per year, paid monthly. It has a total target return of 8% to 10% per year, net of fees and expenses. 

The Trust also has a distribution reinvestment plan (DRP), which allows its shareholders to reinvest their monthly income distributions.

The ASX dividend share’s most recent payout to shareholders was an unfranked 1.11-cent dividend paid earlier this month. The Trust paid out 2.62 cents in July, 1.16 cents in June, and 1.22 cents in April. This translates to a dividend yield of around 9.5%, at the time of writing.

At the time of writing, MOT shares are down around 14% year to date and trading at $1.62 per share.

Plato Income Maximiser Ltd (ASX: PL8)

Plato is another LIC, but one that specifically targets income-focused investors, such as retirees and SMSF investors, who need a dependable income stream. 

The ASX dividend stock holds a portfolio of mature ASX-listed equities, cash, and listed futures. It mostly focuses on Australian companies with strong dividend payouts, such as major banks, mining giants, and energy firms. 

Its goal is to generate a high, franked income stream for investors and to consistently deliver above-market dividends and total returns, including franking credits. 

Plato has consistently paid fully-franked dividends of 0.55 cents per share every month since April 2022. That equates to an annual running total of 6.6 cents per share in fully-franked passive income, yielding around 4.6%.

At the time of writing, Plato shares are trading at $1.40 each, down around 4% for the year to date.

The post 3 ASX dividend shares that pay their investors every single month appeared first on The Motley Fool Australia.

More reading

• How much passive income can I earn off my $800,000 superannuation balance?
• The property market is cooling: Here’s how income investors are adapting
• Expert names 2 top ASX ETFs to buy today
• 3 of the best dividend ASX ETFs right now for passive income
• Why I’d buy these 2 ASX ETFs for $10,000 a year in passive income

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.